Cargando…

RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells

BACKGROUND: Sensitivity of cancer cells to recombinant arginine deiminase (rADI) depends on expression of argininosuccinate synthetase (AS), a rate-limiting enzyme in synthesis of arginine from citrulline. To understand the efficiency of RNA interfering of AS in sensitizing the resistant cancer cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Fe-Lin Lin, Liang, Yu-Fen, Chang, Yuan-Chen, Yo, Hao-Hsin, Wei, Ming-Feng, Shen, Li-Jiuan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080799/
https://www.ncbi.nlm.nih.gov/pubmed/21453546
http://dx.doi.org/10.1186/1423-0127-18-25
_version_ 1782202140105637888
author Wu, Fe-Lin Lin
Liang, Yu-Fen
Chang, Yuan-Chen
Yo, Hao-Hsin
Wei, Ming-Feng
Shen, Li-Jiuan
author_facet Wu, Fe-Lin Lin
Liang, Yu-Fen
Chang, Yuan-Chen
Yo, Hao-Hsin
Wei, Ming-Feng
Shen, Li-Jiuan
author_sort Wu, Fe-Lin Lin
collection PubMed
description BACKGROUND: Sensitivity of cancer cells to recombinant arginine deiminase (rADI) depends on expression of argininosuccinate synthetase (AS), a rate-limiting enzyme in synthesis of arginine from citrulline. To understand the efficiency of RNA interfering of AS in sensitizing the resistant cancer cells to rADI, the down regulation of AS transiently and permanently were performed in vitro, respectively. METHODS: We studied the use of down-regulation of this enzyme by RNA interference in three human cancer cell lines (A375, HeLa, and MCF-7) as a way to restore sensitivity to rADI in resistant cells. The expression of AS at levels of mRNA and protein was determined to understand the effect of RNA interference. Cell viability, cell cycle, and possible mechanism of the restore sensitivity of AS RNA interference in rADI treated cancer cells were evaluated. RESULTS: AS DNA was present in all cancer cell lines studied, however, the expression of this enzyme at the mRNA and protein level was different. In two rADI-resistant cell lines, one with endogenous AS expression (MCF-7 cells) and one with induced AS expression (HeLa cells), AS small interference RNA (siRNA) inhibited 37-46% of the expression of AS in MCF-7 cells. ASsiRNA did not affect cell viability in MCF-7 which may be due to the certain amount of residual AS protein. In contrast, ASsiRNA down-regulated almost all AS expression in HeLa cells and caused cell death after rADI treatment. Permanently down-regulated AS expression by short hairpin RNA (shRNA) made MCF-7 cells become sensitive to rADI via the inhibition of 4E-BP1-regulated mTOR signaling pathway. CONCLUSIONS: Our results demonstrate that rADI-resistance can be altered via AS RNA interference. Although transient enzyme down-regulation (siRNA) did not affect cell viability in MCF-7 cells, permanent down-regulation (shRNA) overcame the problem of rADI-resistance due to the more efficiency in AS silencing.
format Text
id pubmed-3080799
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30807992011-04-22 RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells Wu, Fe-Lin Lin Liang, Yu-Fen Chang, Yuan-Chen Yo, Hao-Hsin Wei, Ming-Feng Shen, Li-Jiuan J Biomed Sci Research BACKGROUND: Sensitivity of cancer cells to recombinant arginine deiminase (rADI) depends on expression of argininosuccinate synthetase (AS), a rate-limiting enzyme in synthesis of arginine from citrulline. To understand the efficiency of RNA interfering of AS in sensitizing the resistant cancer cells to rADI, the down regulation of AS transiently and permanently were performed in vitro, respectively. METHODS: We studied the use of down-regulation of this enzyme by RNA interference in three human cancer cell lines (A375, HeLa, and MCF-7) as a way to restore sensitivity to rADI in resistant cells. The expression of AS at levels of mRNA and protein was determined to understand the effect of RNA interference. Cell viability, cell cycle, and possible mechanism of the restore sensitivity of AS RNA interference in rADI treated cancer cells were evaluated. RESULTS: AS DNA was present in all cancer cell lines studied, however, the expression of this enzyme at the mRNA and protein level was different. In two rADI-resistant cell lines, one with endogenous AS expression (MCF-7 cells) and one with induced AS expression (HeLa cells), AS small interference RNA (siRNA) inhibited 37-46% of the expression of AS in MCF-7 cells. ASsiRNA did not affect cell viability in MCF-7 which may be due to the certain amount of residual AS protein. In contrast, ASsiRNA down-regulated almost all AS expression in HeLa cells and caused cell death after rADI treatment. Permanently down-regulated AS expression by short hairpin RNA (shRNA) made MCF-7 cells become sensitive to rADI via the inhibition of 4E-BP1-regulated mTOR signaling pathway. CONCLUSIONS: Our results demonstrate that rADI-resistance can be altered via AS RNA interference. Although transient enzyme down-regulation (siRNA) did not affect cell viability in MCF-7 cells, permanent down-regulation (shRNA) overcame the problem of rADI-resistance due to the more efficiency in AS silencing. BioMed Central 2011-04-01 /pmc/articles/PMC3080799/ /pubmed/21453546 http://dx.doi.org/10.1186/1423-0127-18-25 Text en Copyright ©2011 Wu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wu, Fe-Lin Lin
Liang, Yu-Fen
Chang, Yuan-Chen
Yo, Hao-Hsin
Wei, Ming-Feng
Shen, Li-Jiuan
RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells
title RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells
title_full RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells
title_fullStr RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells
title_full_unstemmed RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells
title_short RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells
title_sort rna interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (radi) in resistant cancer cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080799/
https://www.ncbi.nlm.nih.gov/pubmed/21453546
http://dx.doi.org/10.1186/1423-0127-18-25
work_keys_str_mv AT wufelinlin rnainterferenceofargininosuccinatesynthetaserestoressensitivitytorecombinantargininedeiminaseradiinresistantcancercells
AT liangyufen rnainterferenceofargininosuccinatesynthetaserestoressensitivitytorecombinantargininedeiminaseradiinresistantcancercells
AT changyuanchen rnainterferenceofargininosuccinatesynthetaserestoressensitivitytorecombinantargininedeiminaseradiinresistantcancercells
AT yohaohsin rnainterferenceofargininosuccinatesynthetaserestoressensitivitytorecombinantargininedeiminaseradiinresistantcancercells
AT weimingfeng rnainterferenceofargininosuccinatesynthetaserestoressensitivitytorecombinantargininedeiminaseradiinresistantcancercells
AT shenlijiuan rnainterferenceofargininosuccinatesynthetaserestoressensitivitytorecombinantargininedeiminaseradiinresistantcancercells